BRIC-Translational Health Science and Technology Institute (THSTI) is an Institute of the Biotechnology Research and Innovation Council, Department of Biotechnology, Ministry of Science & Technology, Govt. of India.

The ECHS Central Organisation is located at Delhi and functions under the Chief of Staff Committee (COSC) through AG and DGDC&W in Army HQ. The Central organisation is headed by Managing Director, ECHS, a serving Major General. There are 28 Regional Centres ECHS and 426 ECHS Polyclinics. ECHS is also an attached office of Dept of Ex-Servivemen Welfare (DoESW), Ministry of Defence (MoD) as are Directorate General Resettlement(DGR) and Kendriya Sainik Board (KSB).

Post : Pharmacist

Manipal School of Life Sciences (MSLS) at Manipal Academy of Higher Education (MAHE), Manipal, established in 2002, gained an independent identity in 2006 and is one of the top biotechnological institutes of the country. It is identified as TIFAC-CORE (Technology Information, Forecasting & Assessment Council - Centres of Relevance & Excellence) under vision 2020 of the Government of India in the area of Pharmacogenomics.

Post : Assistant Professor

The Centre for Brain and Mind (CBM) is an exciting new scientific venture of the National Centre for Biological Sciences (NCBS) and the National Institute for Mental Health & Neurosciences (NIMHANS), supported by Rohini Nilekani Philanthropies.  CBM will undertake cutting-edge research around mental illness with the goal of discovering novel and better methods for the diagnosis and clinical management of mental illness in humans.

Alembic Pharmaceuticals Limited received an Establishment Inspection Report (EIR) for its Oncology (Injectable and Oral Solid) Formulation Facility at Panelav.

On 8th March, 2024, US FDA Inspection at Alembic Pharmaceuticals Limited’s Oncology (Injectable and Oral Solid) Formulation Facility at Panelav.

Gland Pharma Limited, a generic injectable-focused pharmaceutical company, has received approval from the United States Food and Drug Administration (USFDA) for Edaravone Injection, 30 mg/100 mL (0.3 mg/mL) and 60 mg/100 mL (0.6 mg/mL), Single-Dose Bags. 

The Product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Radicava Injection, 30 mg/100 mL (0.3 mg/mL) and 60 mg/100 mL (0.6 mg/mL) of Mitsubishi Tanabe Pharma Corporation. 

AstraZeneca announced that it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a surplus of available updated vaccines since the pandemic.

The company also said it would proceed to withdraw the vaccine Vaxzevria's marketing authorizations within Europe.

Faculty Recruitment 2024 job notification announced by Calcutta Institute of Pharmaceutical Technology & Allied Health Sciences (CIPT & AHS), Uluberia, Howrah, West Bengal for 2024-2025 academic year. Eligible candidates may apply through Email.

Hetero Drugs is an Indian pharmaceutical company and the world’s largest producer of anti-retroviral drugs. Hetero’s business includes APIs, generics, biosimilars, custom pharmaceutical services, and branded generics. Globally renowned, vertically integrated pharmaceutical player engaged in Research and Development (R&D), manufacturing, and marketing of high-quality chemical and biologic medicines across diverse therapeutic areas.

Production Department